Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
December 16, 2016
Assays for the Screening and Characterization of Tau Aggregation Inhibitors
Janet E Rickard, David Horsley, Claude M Wischik, et al.
The New Phytologist
|
April 20, 2021
Is acclimation required for success in high light environments? A case study using Mycelis muralis (L.) Dumort (Asteraceae)
Bruce A Osborne, Gerry T Clabby, David Horsley, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
March 21, 2024
Assays for the Screening and Characterization of Tau Aggregation Inhibitors
David Horsley, Janet E Rickard, Thomas Vorley, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 17, 2014
Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer's disease
Thomas C Baddeley, Jennifer McCaffrey, John M D Storey, et al.
Chemistry & Biodiversity
|
February 13, 2026
New Compounds From the Deep-sea Sponge Mycale lingua
H Poppy Clark, David Horsley, Amanda Serpell-Stevens, et al.
Behavioural Brain Research
|
November 29, 2017
Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease
Silke Frahm, Valeria Melis, David Horsley, et al.
Cellular Signalling
|
June 23, 2024
Rescue of synaptosomal glutamate release defects in tau transgenic mice by the tau aggregation inhibitor hydromethylthionine
Anna L Cranston, Igor Kraev, Mike G Stewart, et al.
European Journal of Pharmacology
|
March 19, 2024
LETC inhibits α-Syn aggregation and ameliorates motor deficiencies in the L62 mouse model of synucleinopathy
Karima Schwab, Silke Frahm, Mandy Magbagbeolu, et al.
Frontiers in Molecular Neuroscience
|
January 30, 2018
A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy
Karima Schwab, Silke Frahm, David Horsley, et al.
The Journal of Biological Chemistry
|
March 12, 2015
Cellular Models of Aggregation-dependent Template-directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer Disease
Charles R Harrington, John M D Storey, Scott Clunas, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Methods in Molecular Biology (Clifton, N.J.)
|
December 16, 2016
Assays for the Screening and Characterization of Tau Aggregation Inhibitors
Janet E Rickard, David Horsley, Claude M Wischik, et al.
The New Phytologist
|
April 20, 2021
Is acclimation required for success in high light environments? A case study using Mycelis muralis (L.) Dumort (Asteraceae)
Bruce A Osborne, Gerry T Clabby, David Horsley, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
March 21, 2024
Assays for the Screening and Characterization of Tau Aggregation Inhibitors
David Horsley, Janet E Rickard, Thomas Vorley, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 17, 2014
Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer's disease
Thomas C Baddeley, Jennifer McCaffrey, John M D Storey, et al.
Chemistry & Biodiversity
|
February 13, 2026
New Compounds From the Deep-sea Sponge Mycale lingua
H Poppy Clark, David Horsley, Amanda Serpell-Stevens, et al.
Behavioural Brain Research
|
November 29, 2017
Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease
Silke Frahm, Valeria Melis, David Horsley, et al.
Cellular Signalling
|
June 23, 2024
Rescue of synaptosomal glutamate release defects in tau transgenic mice by the tau aggregation inhibitor hydromethylthionine
Anna L Cranston, Igor Kraev, Mike G Stewart, et al.
European Journal of Pharmacology
|
March 19, 2024
LETC inhibits α-Syn aggregation and ameliorates motor deficiencies in the L62 mouse model of synucleinopathy
Karima Schwab, Silke Frahm, Mandy Magbagbeolu, et al.
Frontiers in Molecular Neuroscience
|
January 30, 2018
A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy
Karima Schwab, Silke Frahm, David Horsley, et al.
The Journal of Biological Chemistry
|
March 12, 2015
Cellular Models of Aggregation-dependent Template-directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer Disease
Charles R Harrington, John M D Storey, Scott Clunas, et al.
Page
of 2